| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.031 | 0.5 |